Management of a Patient with Ankylosing Spondylitis Type Spondyloarthritis and Latent Tuberculosis Infection (original) (raw)

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab

Valderilio F Azevedo

Reumatismo, 2011

View PDFchevron_right

Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research

Chang-hee Suh

PloS one, 2016

View PDFchevron_right

Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations

Giovanni Lapadula

The Journal of rheumatology. Supplement, 2014

View PDFchevron_right

Pre-extensively drug-resistant tuberculosis spondylodiscitis in an immunocompetent patient: a case report

Hanan RKAIN

Pan African Medical Journal, 2020

View PDFchevron_right

Tuberculosis risk in patients with rheumatologic disease treated with biologic drugs

Emine Argüder

Tuberkuloz ve toraks, 2020

View PDFchevron_right

Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review

Thierry Schaeverbeke

New Scientist, 2011

View PDFchevron_right

Tuberculosis chemoprophylaxis in rheumatoid arthritic patients receiving tumor necrosis factor inhibitors or conventional therapy

Eman Shebl

Egyptian Journal of Chest Diseases and Tuberculosis, 2015

View PDFchevron_right

The Assessment of Tuberculosis in Patients with Inflammatory Rheumatic Diseases Treated with Blockers of the Tumoral Necrosis Alpha Factor: A Retrospective Observational Multicentre Study

Liana Chicea

Romanian Journal of Rheumatology

View PDFchevron_right

Pleural tuberculosis following infliximab therapy for ankylosing spondylitis

Dr. Sharath Madhyastha

Journal of Pharmacology and Pharmacotherapeutics

View PDFchevron_right

Arthritis associated with tuberculosis

A. N Malaviya

Best Practice & Research Clinical Rheumatology, 2003

View PDFchevron_right

The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan

Wei-ting Hung

PLOS ONE

View PDFchevron_right

Increased risk of tuberculosis in patients with rheumatoid arthritis

Miguel Belmonte

2003

View PDFchevron_right

Three Tuberculosis Spondylitis Patients With Resistant Rifampicin From the Transpedicular Debridement Surgery Network

Syaifullah Asmiragani

Malang Respiratory Journal, 2021

View PDFchevron_right

Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study

Dae-hyun Yoo

Journal of Korean Medical Science, 2021

View PDFchevron_right

Tuberculosis Arthritis: Epidemiology, Diagnosis, Treatment

Kow-tong Chen

Clinical Research on Foot & Ankle, 2014

View PDFchevron_right

Active tuberculosis in a patient with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitor

Jacob Horowitz

The Israel Medical Association journal : IMAJ, 2010

View PDFchevron_right

Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis

zehra aydin

2009

View PDFchevron_right

Continuation of Anti-TNF Therapy for Rheumatoid Arthritis in Patients with Active Tuberculosis Reactivated during Anti-TNF Medication is more Beneficial than its Cessation

Tomoshige Matsumoto

Journal of Infectious Diseases and Therapeutics, 2015

View PDFchevron_right

Musculoskeletal Tuberculosis: A Multifaceted Foe

Sauvik Dasgupta

Annals of the National Academy of Medical Sciences (India)

View PDFchevron_right

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

Frederick Wolfe

Arthritis and Rheumatism, 2004

View PDFchevron_right

Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice

Alessandro Sanduzzi, Delia Goletti, Francesca Prignano

Autoimmunity Reviews, 2015

View PDFchevron_right

Conservative treatment of TB Spondylitis in Dorsolumbar and Lumbar spine

Dr. Bimal Kumar Pandey

Nepal Orthopaedic Association Journal, 2014

View PDFchevron_right

How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?

FERNANDO ARIAN SALAZAR QUISPE

Reumatología Clínica, 2017

View PDFchevron_right

Immunosuppressive Treatment of Connective Tissue Disease and Occurrence of Tuberculosis

biram fall

Open Journal of Rheumatology and Autoimmune Diseases, 2020

View PDFchevron_right

Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study

volkan aydin

Journal of Clinical Pharmacy and Therapeutics

View PDFchevron_right

Antirheumatic Drugs and the Risk of Tuberculosis

Daniel Mines

Clinical Infectious Diseases, 2006

View PDFchevron_right

Case reports Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy

Sławomir Jeka

Reumatologia/Rheumatology, 2015

View PDFchevron_right

Management in patient with rheumatoid arthritis and tuberculous arthritis: a case report

Ahmad Heifan

International Journal of Research in Medical Sciences

View PDFchevron_right

Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada

Anne-Marie Lowe, Paul Brassard

Arthritis & Rheumatism, 2009

View PDFchevron_right